PF-07826390

PF-07826390 · Pfizer

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for PF-07826390, covering 2026-02-23 to 2026-02-23. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Learn About How Different Amounts of the Study Medicine PF-07826390 Act in the Body of People With Cancer When Taken Alone or With Other Anti-cancer Medicines. [Phase 1]

See pricing